INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 256 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q2 2018. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,487,174 | -32.7% | 117,496 | +1.1% | 0.00% | -33.3% |
| Q2 2023 | $6,668,859 | 0.0% | 116,162 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $6,668,859 | +18.2% | 116,162 | +15.4% | 0.00% | 0.0% |
| Q4 2022 | $5,643,445 | -99.9% | 100,650 | +9.5% | 0.00% | +50.0% |
| Q3 2022 | $3,893,265,000 | -36.9% | 91,909 | -19.6% | 0.00% | -33.3% |
| Q2 2022 | $6,173,954,000 | -14.5% | 114,269 | +1.7% | 0.00% | 0.0% |
| Q1 2022 | $7,218,519,000 | +2.3% | 112,333 | +6.6% | 0.00% | 0.0% |
| Q4 2021 | $7,056,593,000 | -4.9% | 105,338 | -2.7% | 0.00% | 0.0% |
| Q3 2021 | $7,416,726,000 | +0.8% | 108,305 | +0.5% | 0.00% | 0.0% |
| Q2 2021 | $7,355,930,000 | +0.5% | 107,795 | +1.7% | 0.00% | 0.0% |
| Q1 2021 | $7,320,707,000 | -3.6% | 105,959 | -9.4% | 0.00% | -25.0% |
| Q4 2020 | $7,595,185,000 | +59.1% | 116,993 | +15.7% | 0.00% | +33.3% |
| Q3 2020 | $4,773,801,000 | +6.3% | 101,097 | +5.8% | 0.00% | 0.0% |
| Q2 2020 | $4,491,680,000 | +2.4% | 95,588 | -2.6% | 0.00% | 0.0% |
| Q1 2020 | $4,384,852,000 | -15.2% | 98,161 | +10.7% | 0.00% | 0.0% |
| Q4 2019 | $5,167,980,000 | -12.3% | 88,675 | -9.6% | 0.00% | -25.0% |
| Q3 2019 | $5,890,644,000 | +22.0% | 98,063 | +13.4% | 0.00% | +33.3% |
| Q2 2019 | $4,829,964,000 | +6.4% | 86,481 | +6.2% | 0.00% | 0.0% |
| Q1 2019 | $4,537,892,000 | +32.4% | 81,441 | +7.2% | 0.00% | 0.0% |
| Q4 2018 | $3,427,828,000 | -26.7% | 76,005 | +7.1% | 0.00% | 0.0% |
| Q3 2018 | $4,673,344,000 | +7.9% | 70,948 | +5.5% | 0.00% | 0.0% |
| Q2 2018 | $4,332,023,000 | +46.5% | 67,257 | +25.8% | 0.00% | +50.0% |
| Q1 2018 | $2,957,700,000 | +30.0% | 53,446 | +12.4% | 0.00% | 0.0% |
| Q4 2017 | $2,274,738,000 | +0.6% | 47,529 | +6.1% | 0.00% | 0.0% |
| Q3 2017 | $2,260,696,000 | -3.6% | 44,784 | +4.1% | 0.00% | 0.0% |
| Q2 2017 | $2,345,620,000 | +39.5% | 43,031 | +7.8% | 0.00% | 0.0% |
| Q1 2017 | $1,681,282,000 | +86296.8% | 39,907 | +76.0% | 0.00% | 0.0% |
| Q4 2016 | $1,946,000 | -19.2% | 22,678 | -22.3% | 0.00% | -33.3% |
| Q3 2016 | $2,409,000 | -7.5% | 29,177 | -10.7% | 0.00% | 0.0% |
| Q2 2016 | $2,605,000 | -8.1% | 32,664 | -22.4% | 0.00% | 0.0% |
| Q1 2016 | $2,835,000 | -7.4% | 42,090 | -6.9% | 0.00% | 0.0% |
| Q4 2015 | $3,063,000 | +15.9% | 45,189 | +1.8% | 0.00% | 0.0% |
| Q3 2015 | $2,643,000 | +17.3% | 44,395 | +32.7% | 0.00% | +50.0% |
| Q2 2015 | $2,253,000 | -3.8% | 33,445 | -11.9% | 0.00% | 0.0% |
| Q1 2015 | $2,342,000 | +11.8% | 37,983 | -1.7% | 0.00% | 0.0% |
| Q4 2014 | $2,095,000 | +448.4% | 38,622 | +401.6% | 0.00% | – |
| Q3 2014 | $382,000 | +5.5% | 7,700 | 0.0% | 0.00% | – |
| Q2 2014 | $362,000 | +2.3% | 7,700 | 0.0% | 0.00% | – |
| Q1 2014 | $354,000 | +4.4% | 7,700 | +8.5% | 0.00% | – |
| Q4 2013 | $339,000 | +9.4% | 7,100 | -7.8% | 0.00% | – |
| Q3 2013 | $310,000 | +9.9% | 7,700 | 0.0% | 0.00% | – |
| Q2 2013 | $282,000 | – | 7,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |